Data / Form D filings / Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.: Form D filings
Milestone Pharmaceuticals Inc., a pharmaceuticals company in Montreal, Quebec, Canada, filed 4 Form D notices with the SEC between 2011 and 2018. The latest, on October 26, 2018, reports $80 million sold of a $80 million offering to 16 investors.
Find out what Milestone Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1111 DR. FREDERIK-PHILIPS BLVD, SUITE 420, Montreal, Quebec, Canada, H4M 2
- Phone
- (514) 336-0444
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Quebec, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1408443
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2018 | New notice | $80,000,000 | $80,000,000 | $0 | 16 | Oct 15, 2018 | sec.gov |
| Jul 25, 2017 | New notice | $6,880,072 | $6,880,072 | $0 | 5 | Jul 21, 2017 | sec.gov |
| Jun 15, 2015 | New notice | $9,406,593 | $3,848,369 | $5,558,224 | 3 | Jun 3, 2015 | sec.gov |
| Jun 14, 2011 | New notice | $595,502 | $595,502 | $0 | 2 | May 31, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guy G. Rousseau | Executive Officer | |
| Nilesh G. Kumar | Director | |
| Debra G. Liebert | Director | |
| Paul G. Truex | Director | |
| Francis G. Plat | Executive Officer | |
| Joseph G. Oliveto | Executive Officer, Director | |
| Douglas G. Wight | Executive Officer | |
| Philippe G. Douville | Executive Officer | |
| Marco G. Boorsma | Director | |
| Harish G. Pimplaskar | Executive Officer | |
| Lorenz G. Muller | Executive Officer | |
| Jeff G. Nelson | Executive Officer |
Every Form D from the week of Oct 22, 2018 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Milestone Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.